Medicus Pharma Ltd. Common Stock (MDCX) vs Pluri Inc. (PLUR)
A side-by-side comparison of Medicus Pharma Ltd. Common Stock and Pluri Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 2:04 PM EDT
PLUR
Pluri Inc.
$0.98HealthcareDelayed quote: Oct 6, 2026, 1:51 PM EDT
Total return — MDCX vs PLUR
growth of $100 · dividends reinvested · last 2yMDCX -93.7% (-74.9%/yr)PLUR -80.9% (-56.3%/yr)PLUR compounded faster over this window
MDCX PLUR
MDCX vs PLUR: by the numbers
- •PLUR is the larger company ($11M vs $10M market cap).
- •Both run net losses; MDCX's is the smaller (0.00% vs -2406.00% net margin).
Metrics side by side
Valuation
| Metric | MDCX | PLUR |
|---|---|---|
| P/S ratio | N/A | 10.43 |
Profitability
| Metric | MDCX | PLUR |
|---|---|---|
| Gross margin | 0.00% | 44.59% |
| Operating margin | 0.00% | -2455.91% |
| Net margin | 0.00% | -2406.00% |
| ROIC | -269.16% | -127.37% |
Growth (annualized)
| Metric | MDCX | PLUR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -44.78% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.